{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:53:26Z","timestamp":1771455206518,"version":"3.50.1"},"reference-count":20,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2023,2,2]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The lack of accepted scoring criteria has precluded the use of p53 in routine practice. We evaluate the utility of automated quantitative p53 analysis in risk stratifying Barrett\u2019s oesophagus (BE) patients using non-dysplastic BE (NDBE) biopsies in a multicentric cohort of BE progressor (P) and non-progressor (NP) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>NDBE biopsies prior to the diagnosis of advanced neoplasia from 75 BE-P, and index and last surveillance biopsies from 148 BE-NP were stained for p53, and scored digitally as 1+, 2+ and 3+. A secondary cohort of 30 BE-P was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with BE-NP, BE-P was predominantly men (p=0.001), \u226555 years of age (p=0.008), with longer BE segments (71% vs 33%; p&lt;0.001). The mean number of 3+p53 positive cells and 3+ positive glands were significantly more in BE-P versus BE-NP NDBE biopsies (175 vs 9.7, p&lt;0.001; 9.8 vs 0.1; p&lt;0.001, respectively). At a cut-off of \u226510\u2009p53 (3+) positive cells, the sensitivity and specificity of the assay to identify BE-P were 39% and 93%. On multivariate analysis, scoring p53 in NDBE biopsies, age, gender and length of BE were significantly associated with neoplastic progression. 54% of patients classified as prevalent dysplasia showed an abnormal p53 immunohistochemical stain. These findings were validated in the secondary cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Automated p53 analysis in NDBE biopsies serves as a promising tool for assessing BE neoplastic progression and risk stratification. Our study highlights the practical applicability of p53 assay to routine surveillance practice and its ability to detect prevalent dysplasia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp-2022-208721","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T13:20:53Z","timestamp":1677158453000},"page":"582-590","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative p53 immunostaining aids in the detection of prevalent dysplasia"],"prefix":"10.1136","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5321-190X","authenticated-orcid":false,"given":"Azfar","family":"Neyaz","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Rickelt","sequence":"additional","affiliation":[{"name":"David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer H","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige H","family":"Parrack","sequence":"additional","affiliation":[{"name":"Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyue","family":"Lu","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Y","family":"Wu","sequence":"additional","affiliation":[{"name":"Pathology, Brown University Warren Alpert Medical School, Providence, Rhode Island, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Tak","family":"Choi","sequence":"additional","affiliation":[{"name":"Pathology, University of California, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Gala","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T","family":"Ting","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Odze","sequence":"additional","affiliation":[{"name":"Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-1299","authenticated-orcid":false,"given":"Deepa T","family":"Patil","sequence":"additional","affiliation":[{"name":"Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-9308","authenticated-orcid":false,"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"2025121400593562000_76.9.582.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2006.09.003"},{"key":"2025121400593562000_76.9.582.2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.322"},{"key":"2025121400593562000_76.9.582.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.11.008"},{"key":"2025121400593562000_76.9.582.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31099-0"},{"key":"2025121400593562000_76.9.582.5","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3013"},{"key":"2025121400593562000_76.9.582.6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10620-006-3093-3","article-title":"TP53 gene mutations are rare in nondysplastic barrett\u2019s esophagus","volume":"51","author":"Novotna","year":"2006","journal-title":"Dig Dis Sci"},{"key":"2025121400593562000_76.9.582.7","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800231"},{"key":"2025121400593562000_76.9.582.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2015.02.006"},{"key":"2025121400593562000_76.9.582.9","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-13-0289"},{"key":"2025121400593562000_76.9.582.10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.gastro.2018.03.047","article-title":"Detection of mutations in barrett\u2019s esophagus before progression to high-grade dysplasia or adenocarcinoma","volume":"155","author":"Stachler","year":"2018","journal-title":"Gastroenterology"},{"key":"2025121400593562000_76.9.582.11","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/ijc.32351","article-title":"High-resolution genomic alterations in barrett\u2019s metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma","volume":"145","author":"Sepulveda","year":"2019","journal-title":"Int J Cancer"},{"key":"2025121400593562000_76.9.582.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.040"},{"key":"2025121400593562000_76.9.582.13","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1007\/s00464-020-07950-5","article-title":"Length of barrett\u2019s esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma","volume":"35","author":"Barrie","year":"2021","journal-title":"Surg Endosc"},{"key":"2025121400593562000_76.9.582.14","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000311","article-title":"Longitudinal and circumferential distributions of dysplasia and early neoplasia in barrett\u2019s esophagus: a pooled analysis of three prospective studies","volume":"12","author":"Raphael","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"2025121400593562000_76.9.582.15","unstructured":"Institute NC . Surveillance research program. SEER*explorer software; 2019. Available: seer.cancer.gov\/seerstat"},{"key":"2025121400593562000_76.9.582.16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.083295"},{"key":"2025121400593562000_76.9.582.17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.gastro.2021.10.038","article-title":"Abnormal TP53 predicts risk of progression in patients with barrett\u2019s esophagus regardless of a diagnosis of dysplasia","volume":"162","author":"Redston","year":"2022","journal-title":"Gastroenterology"},{"key":"2025121400593562000_76.9.582.18","doi-asserted-by":"crossref","first-page":"102765","DOI":"10.1016\/j.ebiom.2020.102765","article-title":"Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of barrett\u2019s oesophagus: a multi-centre prospective cohort study","volume":"56","author":"Hadjinicolaou","year":"2020","journal-title":"EBioMedicine"},{"key":"2025121400593562000_76.9.582.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303594"},{"key":"2025121400593562000_76.9.582.20","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13783"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2022-208721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:59:45Z","timestamp":1765702785000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2022-208721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,8,17]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/jcp-2022-208721"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2022-208721","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]}}}